Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Sociodemographic Characterization of Multiple Myeloma Patients With Symptomatic Relapse and/or Refractory Disease in Portugal: an Observational, Multicenter Study

NCT04135963 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04135963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04135963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Sociodemographic Characterization of Multiple Myeloma Patients With Symptomatic Relapse and/or Refractory Disease in Portugal: an Observational, Multicenter Study
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
July 31, 2020
Completion date
September 30, 2022
Enrollment
62 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

relapse and/or refractory multiple myeloma